1 / 1

SEARCH

SEARCH. No difference in the incidence of major vascular events between high- vs. low-dose simvastatin, or folate + vitamin B 12 vs. placebo (p > 0.05 for both) No difference in individual outcomes studied

jordan-savage
Download Presentation

SEARCH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SEARCH No difference in the incidence of major vascular events between high- vs. low-dose simvastatin, or folate + vitamin B12 vs. placebo (p > 0.05 for both) No difference in individual outcomes studied ↑ risk of myopathy in high-dose vs. low-dose simvastatin arms (0.88% vs. 0.05%, p < 0.05) (p > 0.05) (p > 0.05) Trial design: A 2 x 2 factorial study in which patients with a recent MI were randomized to either simvastatin 80 mg or 20 mg daily, and folic acid + vitamin B12 or placebo. Patients were followed for a mean of 6.7 years. Results 50 50 % % 25.7 24.5 25.5 24.8 0 0 Conclusions Major vascular events • Neither high-dose (vs. low-dose) simvastatin nor folate + vitamin B12 (vs. placebo) effective in reducing major vascular events in patients with a recent MI • Statin data contrary to other trials on this topic, folate + vitamin B12 data similar Folate/ Vit B12 n = 6,033 Simvastatin 80 mg n = 6,031 Simvastatin 20 mg n = 6,033 Placebo n = 6,031 Presented by Dr. Rory Collins at AHA 2008

More Related